We are excited to launch a new, open access journal, *Molecular Genetics and Metabolism* (*MGM*) *Reports*, which will complement *MGM* and provide an additional platform for you, our fantastic authors, to publish your important contributions. It is rewarding to be a member of a field of biomedical inquiry that is so vigorous that it justifies a new journal.

The *MGM* Editorial Board has been discussing the future of investigations and publications in metabolic disorders, specifically the impact of whole exome and whole genome sequencing. *MGM* publishes articles that provide functional molecular insights into the pathogenesis and treatment of these diseases. The Editorial Board members anticipated that there will be increasing numbers of articles that publish sequencing observations without functional data --- case reports in the sequencing era. These are significant contributions and they require a venue for publication, where they can be archived and retrieved. These will be the new *Sequence Reports*.

In addition to this new manuscript type, *MGM Reports* will publish routinely: *Molecular and Metabolic Reports*, similar to original articles; *Brief Reports*, representing brief communications; and *Letters to the Editor*. On an occasional basis, this new journal may choose to include other manuscript formats, such as *Conference Reports*, representing meeting proceedings.

The manuscripts in *MGM Reports* will only include preliminary reports that have adequate supporting data. These manuscripts will be reviewed for impact on the field and contribution to future scholarship and/or clinical insight.

You can continue to expect the rapid and decisive editorial judgments for *MGM Reports* that you have come to expect from *MGM*. This process will be enhanced by the manuscript-transfer system. Review by *MGM*, *MGM Reports* or *Gene* can serve for editorial consideration by any one of these three publications. Manuscripts not only will be reviewed rapidly, but also will be published online rapidly and available to all.

Thank you for your contributions to the field of metabolic disorders, and for your interest in *MGM* and *MGM Reports*. We look forward to bringing you the latest research in the areas of molecular genetics and metabolism.
